Lot of truth in there. Sometimes that approach works. But if you want to get in the bigboys territory and get FDA approved for a drug--the shortcut and small trial will not work. The RCT with sufficient numbers to prove up your p value --not gonna be cheap. Even if they can go botanical drug, still $$$ The key is (IMO) the revenue coming in from Tollovid sales and the (looks cyclical)testing revenue. IF that revenue is close or above the burn rate for a few months it can be done. That is gonna need more of the lockup stuff (no cheating) on shares. They are spending for the AZ testing/salaries and the videssa testing/salaries. Both have GREAT market potential. But still have to get approval then sales. I heard him talk about getting our own manuf. for Tollovid and there will be new generations of Tollovid.
PLEASE PLEASE get some country or partner to help w trials. This is good solid proven science. I really hope Israel will give EUA now w what we have. Maybe another domino or 2. C'mon Commish
News 
Market Data 
Discover 
AI
